Hematopoietic Subsyndrome of Acute Radiation Syndrome

DBCOND0020289Digestive System Diseases Disease and Non-Disease Concepts, Unclassified

Hematopoietic Subsyndrome of Acute Radiation Syndrome is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as: Acute Radiation Syndrome · Hematopoietic Syndrome Due to Acute Radiation Syndrome
Classified under: Digestive System Diseases
Disease and Non-Disease Concepts, Unclassified
Healthcare Systems and Public Health
Signs, Symptoms, and General Pathologies
Skin and Subcutaneous Tissue Diseases
Wounds and Injuries
Indicated drugs: Filgrastim
Pegfilgrastim
Sargramostim

Resolves to

Vocabularies

MeSHM0505750SNOMED CT1260191006MedDRA10001036UMLSC0520799

What you can answer from here — as of October 23, 2026

3Indicated drugsWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

9Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Hematopoietic Subsyndrome of Acute Radiation Syndrome share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account